Navigating Regulatory Pathways and the Role of Bioanalytical Testing
The journey of a novel cardiac biomarker from a laboratory discovery to a commercially available diagnostic tool is notoriously complex. For developers operating within the Cardiac Biomarkers Market, the regulatory landscape presents both the highest barrier to entry and the most critical validation of their product's efficacy. Understanding the rigorous testing required by global agencies is...
0 Comments 0 Shares 157 Views 0 Reviews